NeonMind Biosciences Inc. Press Releases

• Published on April 21, 2022 - 11:30 GMT

  

  NeonMind to Improve Patient Care and Data Management by Adopting Digital Platform for Ketamine Treatments

  NeonMind Biosciences Inc. (OTCQB:NMDBF) OAKVILLE, ONTARIO, CANADA, April 21, 2022 /⁨EINPresswire.com⁩/ -- : NeonMind Biosciences Inc. (CSE: NEON) (OTCQB: NMDBF) (FRA: 6UF) (“NeonMind'' or the “Company”), announced today it has advanced its …

  Distribution channels: Business & Economy, Companies ...
• Published on April 19, 2022 - 23:19 GMT

  

  NeonMind Engages Leading Digital Platform for Medical Education and Adoption of Ketamine Treatments

  Initiates Medical Adoption Program with Impetus Digital, a Leading Healthcare Platform for Virtual Medical Education NeonMind Biosciences Inc. (OTCQB:NMDBF) OAKVILLE, ONTARIO, CANADA, April 19, 2022 /⁨EINPresswire.com⁩/ -- Oakville, Ontario – April 19, …

  Distribution channels: Companies, Consumer Goods ...
• Published on April 12, 2022 - 11:00 GMT

  

  NeonMind Announces Plan to Launch 10 Clinics for Innovative Treatments as Mental Health Crisis Grows

  Partnered with SRx Health Solutions and BioScript Solutions to Build Out a Network of NeonMind-branded Specialty Mental Health Clinics Across Canada NeonMind Biosciences Inc. (OTCQB:NMDBF) OAKVILLE, ONTARIO, CANADA, April 12, 2022 /⁨EINPresswire.com⁩/ -- …

  Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...